| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.00091 | 1 |